EGFR and breast cancer: LIPTACs exhibited efficient EGFR degradationon triple-negative breast cancer cell line HCC1143 (Figure S4c), the pancreatic cancer cell line PANC-1 (Figure S4d), as well as the nonsmall cell lungcancer cell line NCI-H1975 (Figure S4e).